Y. Narahara

发表

Lead‐in treatment with interferon‐β/ribavirin may modify the early hepatitis C virus dynamics in pegylated interferon alpha‐2b/ribavirin combination for chronic hepatitis C patients with the IL28B minor genotype

A. Tsubota, K. Iwakiri, C. Sakamoto, 2013, Journal of gastroenterology and hepatology.

Combination of fluvastatin with pegylated interferon/ribavirin therapy reduces viral relapse in chronic hepatitis C infected with HCV genotype 1b

A. Tsubota, C. Sakamoto, Tamaki Kobayashi, 2013, Journal of gastroenterology and hepatology.

An open‐label randomized controlled study of pegylated interferon/ribavirin combination therapy for chronic hepatitis C with versus without fluvastatin

A. Tsubota, C. Sakamoto, M. Atsukawa, 2012, Journal of viral hepatitis.

Serum 25‐hydroxyvitamin D3 levels affect treatment outcome in pegylated interferon/ribavirin combination therapy for compensated cirrhotic patients with hepatitis C virus genotype 1b and high viral load

A. Tsubota, K. Iwakiri, C. Sakamoto, 2014, Hepatology research : the official journal of the Japan Society of Hepatology.

Effects of transjugular intrahepatic portosystemic shunt (TIPS) on esophageal motor function and gastroesophageal reflux

K. Iwakiri, T. Sugiura, M. Kotoyori, 1998, Journal of Gastroenterology.

Wedged Hepatic Venous Pressure Does Not Reflect Portal Pressure in Patients with Cirrhosis and Hepatic Veno–Venous Communications

C. Sakamoto, Y. Narahara, K. Nakatsuka, 2007, Digestive Diseases and Sciences.

Usefulness of portal vein pressure for predicting the effects of tolvaptan in cirrhotic patients.

A. Tsubota, K. Iwakiri, M. Atsukawa, 2016, World journal of gastroenterology.

Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis

C. Sakamoto, M. Atsukawa, T. Fukuda, 2009, Journal of gastroenterology and hepatology.

Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.

C. Sakamoto, Y. Narahara, K. Nakatsuka, 2004, Hepatology research : the official journal of the Japan Society of Hepatology.

[Transjugular intrahepatic portosystemic shunt for the treatment of refractory ascites].

T. Kumazaki, Y. Narahara, H. Kanazawa, 1998, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology.

Efficacy of Alfacalcidol on PEG-IFN/ Ribavirin Combination Therapy for Elderly Patients With Chronic Hepatitis C: A Pilot Study

A. Tsubota, K. Iwakiri, C. Sakamoto, 2013, Hepatitis monthly.

Predictive factors for improvement of ascites after transjugular intrahepatic portosystemic shunt in patients with refractory ascites

C. Sakamoto, M. Atsukawa, N. Itokawa, 2014, Hepatology research : the official journal of the Japan Society of Hepatology.

The effect of octreotide on fasting and postprandial splanchnic hemodynamics in cirrhosis.

Y. Narahara, H. Kanazawa, Y. Taki, 2004, Hepatology research : the official journal of the Japan Society of Hepatology.

Two cases of alcoholic liver cirrhosis with diffuse intrahepatic arterio-portal shunt treated by transjugular intrahepatic portosystemic shunt

C. Sakamoto, Tamaki Kobayashi, M. Atsukawa, 2011 .

Small Intestinal Edema Had the Strongest Correlation with Portal Venous Pressure amongst Capsule Endoscopy Findings

C. Sakamoto, Masahiro Suzuki, K. Gudis, 2012, Digestion.

Effects of transjugular intrahepatic portosystemic shunt on changes in the small bowel mucosa of cirrhotic patients with portal hypertension

C. Sakamoto, S. Fujimori, M. Atsukawa, 2013, Journal of Gastroenterology.

Transjugular intrahepatic portosystemic shunt for the treatment of refractory hepatic hydrothorax

K. Iwakiri, T. Fukuda, H. Kidokoro, 2020 .

[A case of refractory hepatic hydrothorax successfully treated with transjugular intrahepatic portosystemic shunt].

C. Sakamoto, M. Atsukawa, H. Kidokoro, 2003, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology.

Transjugular intrahepatic portosystemic shunt versus paracentesis plus albumin in patients with refractory ascites who have good hepatic and renal function: a prospective randomized trial

C. Sakamoto, M. Atsukawa, T. Fukuda, 2010, Journal of Gastroenterology.

A case of IgG4-related disease with rectal cancer

C. Sakamoto, M. Atsukawa, N. Itokawa, 2011, Clinical journal of gastroenterology.

A randomized clinical trial comparing transjugular intrahepatic portosystemic shunt with endoscopic sclerotherapy in the long-term management of patients with cirrhosis after recent variceal hemorrhage.

C. Sakamoto, Masafumi Kobayashi, S. Matsuzaka, 2001, Hepatology research : the official journal of the Japan Society of Hepatology.

The efficacy and safety of terlipressin and albumin in patients with type 1 hepatorenal syndrome: a multicenter, open-label, explorative study

O. Yokosuka, K. Okita, Y. Matsuzaki, 2012, Journal of Gastroenterology.

The efficacy and safety of terlipressin and albumin in patients with type 1 hepatorenal syndrome: a multicenter, open-label, explorative study Yoshiyuki NaraharaHidenori KanazawaChoitsu SakamotoHitoshi Maruyama • Osamu YokosukaSatoshi MochidaMasahito UemuraHiroshi FukuiYasukiyo Sumino •

O. Yokosuka, K. Okita, Y. Matsuzaki, 2011 .

Effect of fluvastatin on 24-week telaprevir-based combination therapy for hepatitis C virus genotype 1b-infected chronic hepatitis C

A. Tsubota, Hiroki Yamaguchi, K. Iwakiri, 2014, European journal of gastroenterology & hepatology.

For Peer Review Fluvastatin does not exhibit an add -on effect on pegylated - interferon/ribavirin/telaprevir therapy for HCV genotype 1b-infected chronic hepatitis C

A. Tsubota, K. Iwakiri, C. Sakamoto, 2013 .

Effects of fasudil on the portal and systemic hemodynamics of patients with cirrhosis

C. Sakamoto, M. Atsukawa, N. Itokawa, 2014, Journal of gastroenterology and hepatology.